Gold Nanoparticles for Photothermal Cancer Therapy.

Vines JB, Yoon JH, Ryu NE, Lim DJ, Park H. · 2019

Read Gold Nanoparticles for Photothermal Cancer Therapy. by Vines JB, Yoon JH, Ryu NE, Lim DJ, Park H. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6460051.txt.

Introduction

Vines and co-authors review gold nanoparticles for photothermal cancer therapy, where particles parked inside a tumor convert light into tumor-killing heat. Gold has served medicine for centuries and shrinks well to the nanoscale, where its surface can carry antibodies or drugs. Its localized surface plasmon resonance lets it absorb chosen wavelengths, including near-infrared that reaches deeper tissue.

Tuning particle size and shape tunes the heating and the photoacoustic signal used for imaging. Particles drift passively into tumors through leaky vessels and can exit through the urinary system. Synthesis routes, including greener biological ones, and targeting strategies fill the middle sections, with clinical translation still ahead.

Catalog record

CREATORVines JB, Yoon JH, Ryu NE, Lim DJ, Park H.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE85 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6460051

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Gold Nanoparticles for Photothermal Cancer Therapy By Jeremy B Vines, Jee-Hyun Yoon, Na-Eun Ryu, Dong-Jin Lim, Hansoo Park Published in: Frontiers in Chemistry DOI: 10.3389/fchem.2019.00167 ABSTRACT Abstract Gold is a multifunctional material that has been utilized in medicinal applications for centuries because it has been recognized for its bacteriostatic, anticorrosive, and antioxidative properties. Modern medicine makes routine, conventional use of gold and has even developed more advanced applications by taking advantage of its ability to be manufactured at the nanoscale and functionalized because of the presence of thiol and amine groups, allowing for the conjugation of various functional groups such as targeted antibodies or drug products. It has been shown that colloidal gold exhibits localized plasmon surface resonance (LPSR), meaning that gold nanoparticles can absorb light at specific wavelengths, resulting in photoacoustic and photothermal properties, making them potentially useful for hyperthermic cancer treatments and medical imaging applications. Modifying gold nanoparticle shape and size can change their LPSR photochemical activities, thereby also altering their photothermal and photoacoustic properties, allowing for the utilization of different wavelengths of light, such as light in the near-infrared spectrum. By manufacturing gold in a nanoscale format, it is possible to passively distribute the material through the body, where it can localize in tumors (which are characterized by leaky blood vessels) and be safely excreted through the urinary system. In this paper, we give a quick review of the structure, applications, recent advancements, and potential future directions for the utilization of gold nanoparticles in cancer therapeutics. Keywords: gold, photo-active property, hyperthermia, nanoparticles, cancer therapeutics INTRODUCTION Current Limitations in Conventional Cancer Therapies In 2017, cancer was the second-most common cause of death in the United States, comprising 22.5% of the total number of deaths; 591,699 people died from complications related to cancer in 2017 (Heron, 2018). Unfortunately, owing to the heterogeneous nature of cancer, there are currently no fully comprehensive approaches for treatment; options are mainly limited to chemotherapy, radiotherapy, immunotherapy, and surgery. Although these approaches provide some therapeutic efficacy, they are limited by their risk to normal, healthy cells, their potential to destroy the immune system, or by conferring an increased risk for the development of secondary cancers (Nolsoe et al., 1993; Vogel and Venugopalan, 2003; Kievit and Zhang, 2011). For this reason, a large body of cancer therapy research focuses on finding effective therapies that can complement or even replace current therapies by improving efficacy and reducing inadvertent side effects. Hyperthermia as a Cancer Treatment Modality In the pursuit of therapies capable of reducing undesired side effects and enhancing efficacy, there has been growing interest in utilizing hyperthermia to achieve these goals. Hyperthermic cancer therapy was originally developed based on historical examples in which cancer patients infected by erysipelas had high fevers that either reduced cancer symptoms or resulted in the complete regression of tumors (Moyer and Delman, 2008). Since the original study pioneered by Coley in 1893, additional studies have been performed in which hyperthermia was carefully applied to general regions of cancerous tumor growth to maintain tissue temperatures of around 42 to 45°C (Luk et al., 1980). In practical settings, however, the ability to precisely manage heating surrounding the tumor area would be critical to improve and adapt this alternative modality on cancer treatment. Additionally, other cancer treatment modalities such as radiation and chemotherapy can be utilized together for successful cancer treatment. In this regard, not only does hyperthermia cause apoptosis of cancer cells, but can also improve therapeutic efficacy when used in concert with radiation or chemotherapy (Kampinga, 2006). In the presence of thermal stress, tumors become radiosensitized, making them more likely to respond to radiotherapy, resulting in improved cancer survival rates. This fact has been demonstrated in studies of metastatic head and neck squamous cell cancers, where radical radiation treatment with hyperthermia resulted in improved outcomes without increasing toxicity (Moyer and Delman, 2008; Kaur et al., 2011). A similar sensitization is further seen with chemotherapeutics when used in combination with hyperthermia. When clinically-relevant drugs for malignant melanoma are combined with low or high grade hyperthermia (43 and 45°C, respectively), intrinsic or extrinsic ER-mediated apoptosis can be induced (Mantso et al., 2018). Many preclinical studies have been performed to demonstrate that both radio and chemotherapy can be enhanced by simultaneously incorporating hyperthermic therapy (Peeken et al., 2017). Unfortunately, traditional hyperthermia techniques are not ideal due to the fact that they are not minimally invasive, and result in the non-specific generation of heat throughout the body (Kaur et al., 2016). As a result, substantial undesirable side effects are created. For example, whole-body hyperthermia may cause cardiovascular side effects and gastrointestinal symptoms (Chatterjee et al., 2011). Regarding this, a more promising modality for cancer treatment would involve a targeted, nanoparticle-mediated localized hyperthermia One treatment modality that continues to gain attention and is currently under investigation for potential widespread use is photothermal therapy (PTT) (Bardhan et al., 2011; Melancon et al., 2011). Photothermal therapy is based on the conversion of light energy (usually in the near-infrared region) into heat energy to induce subsequent cellular necrosis or apoptosis (Ray et al., 2012). Compared with other methods, light is an ideal external stimulus as it is easily regulated, focused, and remotely controlled. This ease of focus and control enable better targeted treatments that lead to less damage to healthy tissues (Yang X. et al., 2012; Khaletskaya et al., 2013; Zhu et al., 2014). Unfortunately, traditional photodynamic therapy (PDT) of tissues mediated by laser or visible light is limited by insufficient depth of penetration, limiting its usefulness for deep tumor therapy (Ochsner, 1997; Wilson and Patterson, 2008; Benov, 2015). However, near-infrared (NIR) light (in the wavelength range of 800–1,200 nm) has much greater body transparency, making it preferable for PTT. In contrast to traditional PDT, which relies on the presence of oxygen to generate reactive oxygen species, and is considerably limited in application due to its limited depth of penetration (Wilson and Patterson, 2008), PTT mainly exerts effects by increasing the local temperature within tumors (Wang and Qiu, 2016). Regarding this, it has been demonstrated that in order to completely destroy cancer cells in vitro, a threshold temperature ranging between 70 and 80°C is required (Huang et al., 2006). Furthermore, at temperatures ranging from 55 to 95°C, tumorigenic damage is evident in vivo conditions (Thomsen, 1991). Hyperthermic Nanoparticle Systems and Limitations Some current nanoparticle technologies for hyperthermic therapy include ferromagnetic nanoparticles such as iron oxide (van Landeghem et al., 2009; Wang et al., 2010; Cassim et al., 2011; Maier-Hauff et al., 2011), doped iron oxide (Lee et al., 2011; Fantechi et al., 2014; Gordon et al., 2014) and super-paramagnetic iron oxide nanoparticles (SPION) (Le Renard et al., 2010; Kruse et al., 2014; Zheng et al., 2014) as well as carbon nanotube (CNT) technologies including single walled carbon nanotubes (SWCNTs) and multi-walled carbon nanotubes (MWCNTs) (Burke et al., 2009; Huang et al., 2010) in addition to various polymer-based technologies (Kaur et al., 2016). Ferromagnetic nanoparticles including SPION, iron oxide, and doped iron oxide are typically stimulated under the presence of alternating magnetic fields (AMFs) during which materials are induced to rapidly magnetize and demagnetize. When these materials are manufactured as nanoparticles, their magnetization rapidly fluctuates generating a net field of

Read the complete text